Heller SR - Search Results

1

Association of elevated insulin-like growth factor binding protein-1 with insulin resistance in hyperthyroidism.

Jenkins RC, Valcavi R, Zini M, Frasoldati A, Heller SR, Camacho-Hubner C, Gibson JM, Westwood M, Ross RJ. Jenkins RC, et al. Among authors: heller sr. Clin Endocrinol (Oxf). 2000 Feb;52(2):187-95. doi: 10.1046/j.1365-2265.2000.00924.x. Clin Endocrinol (Oxf). 2000. PMID: 10671946 Clinical Trial.

2

The use of tolbutamide-induced hypoglycemia to examine the intraislet role of insulin in mediating glucagon release in normal humans.

Peacey SR, Rostami-Hodjegan A, George E, Tucker GT, Heller SR. Peacey SR, et al. Among authors: heller sr. J Clin Endocrinol Metab. 1997 May;82(5):1458-61. doi: 10.1210/jcem.82.5.3910. J Clin Endocrinol Metab. 1997. PMID: 9141533

3

Asian women are at increased risk of gestational thyrotoxicosis.

Price A, Davies R, Heller SR, Milford-Ward A, Weetman AP. Price A, et al. Among authors: heller sr. J Clin Endocrinol Metab. 1996 Mar;81(3):1160-3. doi: 10.1210/jcem.81.3.8772593. J Clin Endocrinol Metab. 1996. PMID: 8772593

4

Diabetic hypoglycaemia.

Heller SR. Heller SR. Baillieres Best Pract Res Clin Endocrinol Metab. 1999 Jul;13(2):279-94. doi: 10.1053/beem.1999.0020. Baillieres Best Pract Res Clin Endocrinol Metab. 1999. PMID: 10761867 Review.

5

Chromium homeostasis in patients with type II (NIDDM) diabetes.

Morris BW, MacNeil S, Hardisty CA, Heller S, Burgin C, Gray TA. Morris BW, et al. J Trace Elem Med Biol. 1999 Jul;13(1-2):57-61. doi: 10.1016/S0946-672X(99)80024-8. J Trace Elem Med Biol. 1999. PMID: 10445219

6

Insulin analogues.

Heller SR. Heller SR. Curr Med Res Opin. 2002;18 Suppl 1:s40-7. doi: 10.1185/030079902125000228. Curr Med Res Opin. 2002. PMID: 12365818 Review.

7

Reducing hypoglycaemia with insulin analogues.

Heller S. Heller S. Int J Obes Relat Metab Disord. 2002 Sep;26 Suppl 3:S31-6. doi: 10.1038/sj.ijo.0802175. Int J Obes Relat Metab Disord. 2002. PMID: 12174321 Review.

8

Effect of the fast-acting insulin analog lispro on the risk of nocturnal hypoglycemia during intensified insulin therapy. U.K. Lispro Study Group.

Heller SR, Amiel SA, Mansell P. Heller SR, et al. Diabetes Care. 1999 Oct;22(10):1607-11. doi: 10.2337/diacare.22.10.1607. Diabetes Care. 1999. PMID: 10526722 Clinical Trial.

9

Does insulin lispro preserve the physiological defences to hypoglycaemia during intensive insulin therapy with a conventional basal bolus regimen?

Heller SR, Amiel SA, Evans ML, Kong MF, Macdonald IA, Peacey SR. Heller SR, et al. Diabetes Obes Metab. 2002 Mar;4(2):106-12. doi: 10.1046/j.1463-1326.2002.00186.x. Diabetes Obes Metab. 2002. PMID: 11940107 Clinical Trial.

10

Peacey SR, George E, Rostami-Hodjegan A, Bedford C, Harris N, Hardisty CA, Tucker GT, Macdonald IA, Heller SR. Peacey SR, et al. Among authors: heller sr. Diabet Med. 1996 Jul;13(7):634-41. doi: 10.1002/(SICI)1096-9136(199607)13:7<634::AID-DIA136>3.0.CO;2-Z. Diabet Med. 1996. PMID: 8840097

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

214 results

Search Page

Filters